Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2011-06-14
2011-06-14
Tate, Christopher R (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C424S400000, C424S439000
Reexamination Certificate
active
07959951
ABSTRACT:
The invention relates to nitric oxide (NO) stimulating extracts from various plants. Such extracts contain compounds known as healthin I and healthin II. Specifically, the invention provides partially purified plant extracts that have NO stimulating activity, methods of isolating and partially purifying such extracts from plant materials. In addition, the invention provides methods and materials for treating diseases and conditions that require modification of cellular levels of NO, for example, diseases and conditions involving inflammation.
REFERENCES:
patent: 5162037 (1992-11-01), Whitson-Fischman
patent: 6200594 (2001-03-01), Ernest et al.
patent: 6232528 (2001-05-01), Scorza et al.
patent: 6254899 (2001-07-01), Shrivastava
patent: 6417349 (2002-07-01), Kim et al.
patent: 6432454 (2002-08-01), Shan et al.
patent: 6646013 (2003-11-01), Barker et al.
PDR for Herbal Medicine, First Edition, Salix Species, pp. 1111-1112, copyrighted 1998.
The Healing Herbs, The Ultimate Guide to the Curative Power of nature's Medicines, White Willow, pp. 369-371, copyrighted 1991.
Bilfinger et al., “Pharmacological Evidence for Anandamide Amidase in Human Cardiac and Vascular Tissues,” International Journal of Cardiology, vol. 64, Suppl. 1, pp. S15-S22, 1998.
Bilfinger et al., “Human Aortocoronary Grafts and Nitric Oxide Release: Relationship to Pulsatile Pressure,” Annals of Thoracic Surgery, vol. 69, pp. 480-485, 2000.
Deutsch et al., “Production and Physiological Actions of Anandamide in the Vasculature of the Rat Kidney,” Journal of Clinical Investigation, vol. 100, No. 6, pp. 1538-1546, 1997.
Fimiani et al., “Opiate, Cannabinoid, and Eicosanoid Signaling Converges on Common Intracellular Pathways Nitric Oxide Coupling,” Prostaglandins and Other Lipid Mediators, vol. 57, pp. 23-34, 1999.
Fimiani et al., “Morphine and Anandamide Stimulate Intracellular Calcium Transients in Human Arterial Endothelial Cells: Coupling to Nitric Oxide Release,” Cellular Signaling, vol. 11, No. 3. pp. 189-193, 1999.
Magazine et al., “Morphine-Induced Conformational Changes in Human Monocytes, Granulocytes, and Endothelial Cells and in Invertebrate Immunocytes and Microglia are Mediated by Nitric Oxide1,” Journal of Immunology, vol. 156, pp. 4845-4850, 1996.
Prevot et al., “Estradiol Coupling to Endothelial Nitric Oxide Stimulates Gonadotropin-Releasing Hormone Release from Rat Median Eminence Via a Membrane Receptor,” Endocrinology, vol. 140, No. 2, pp. 652-659, 1999.
Prevot et al., “Morphine and Anandamide Coupling to Nitric Oxide Stimulates GnRH and CRF Release from Rat Median Eminence: Neurovascular Regulation,” Brain Research, vol. 790, pp. 236-244, 1998.
Salzet et al., “Leech Immunocytes Contain Proopiomelanocortin: Nitric Oxide Mediates Hemolymph Proopiomelanocortin Processing1,” Journal of Immunology, vol. 159, pp. 5400-5411, 1997.
Salzet et al., “Invertebrate Proenkephalin: δ Opioid Binding Sites in Leech Ganglia and Immunocytes,” Brain Research, vol. 768, pp. 224-232, 1997.
Sonetti et al., “Microglia in Invertebrate Ganglia,” Proc. Natl. Acad. Sci. USA, vol. 91, pp. 9180-9184, Sep. 1994.
Stefano, G. B., “Autoimmunovascular Regulation: Morphine and Anandamide Stimulated Nitric Oxide Release,” Journal of Neuroimmunology, vol. 83, pp. 70-76, 1998.
Stefano et al., “Stimulatory Effects of Opioid Neuropeptides on Locomotory Activity and Conformational Changes in Invertebrate and Human Immunocytes: Evidence for a Subtype of δ Receptor,” Proc. Natl. Acad. Sci. USA, vol. 86 pp. 6307-6311, Aug. 1989.
Stefano et al., “Presence of the μ3 Opiate Receptor in Endothelial Cells: Coupling to Nitric Oxide Production and Vasodilation,” Journal of Biological Chemistry, vol. 270, No. 51, pp. 30290-30293, 1995.
Stefano et al., “Evidence for the Involvement of Opioid Neuropeptides in the Adherence and Migration of Immunocompetent Invertebrate Hemocytes,” Proc. Natl. Acad. Sci. USA, vol. 86, pp. 626-630, Jan. 1989.
Stefano et al., “Cannabinoid Receptors are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes,” Journal of Biological Chemistry, vol. 271, No. 32, pp. 19238-19242, 1996.
Stefano et al., “[D-Ala2]Deltorphin I Binding and Pharmacological Evidence for a Special Subtype of δ Opioid Receptor on Human and Invertebrate Immune Cells,” Proc. Natl. Acad. Sci. USA, vol. 89, pp. 9316-9320, Oct. 1992.
Stefano et al., “Mytilus edulisHemolymph Contains Pro-Opiomelanocortin: LPS and Morphine Stimulate Differential Processing,” Molecular Brain Research, vol. 63, pp. 340-350, 1999.
Stefano et al., “Enkelytin and Opioid Peptide Association in Invertebrates and Vertebrates: Immune Activation and Pain,” Immunology Today, vol. 19, No. 6, pp. 265-268, Jun. 1998.
Stefano et al., “Morphine- and Anandamide-Stimulated Nitric Oxide Production Inhibits Presynaptic Dopamine Release,” Brain Research, vol. 763, pp. 63-68, 1997.
Stefano et al., “Invertebrate Opioid Precursors: Evolutionary Conservation and the Significance of Enzymatic Processing,” International Reviews Cytol., vol. 187, pp. 261-186, 1999.
Stefano et al., “Long-Term Exposure of Human Blood Vessels to HIV gp120, Morphine, and Anandamide Increases Endothelial Adhesion of Monocytes: Uncoupling of Nitric Oxide Release,” Journal of Cardiovascular Pharmacology, vol. 31, pp. 862-868, 1998.
Stefano et al., “Antagonism of LPS and IFN-γ Induction of iNOS in Human Saphenous Vein Endothelium by Morphine and Anandamide by Nitric Oxide Inhibition of Adenylate Cyclase,” Journal of Cardiovascular Pharmacology, vol. 31, pp. 813-820, 1998.
Stefano et al., “Macrophage Behavior Associated with Acute and Chronic Exposure to HIV GP120, Morphine and Anandamide: Endothelial Implications,” International Journal of Cardiology, vol. 64, Suppl. 1, pp. S3-S13, 1998.
Stefano et al., “The Presence of the μ3 Opiate Receptor in Invertebrate Neural Tissues,” Comp. Biochem. Physiol., vol. 113C, No. 3, pp. 369-373, 1996.
Bilfinger et al., “Direct Assessment and Diminished Production of Morphine Stimulated NO by Diabetic Endothelium from Saphenous Vein,” Acta Pharmacologica Sinica, vol. 23, No. 2, pp. 97-102. Feb. 2002.
Stefano et al., “Cell-Surface Estrogen Receptors Mediate Calcium-Dependent Nitric Oxide Release in Human Endothelia,” Circulation, vol. 101, pp. 1594-1597, 2000.
Chen, S. et al., “Molluscicidal Saponins from Allium Vineale,” Tetrahedron Letters, vol. 28, No. 46 (1987), pp. 5603-5606.
Surh, Y.-J. et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kB activation,” Mutation Research 480-481 (2001), pp. 243-268.
Murphy, L.L. et al., “Ginseng, Sex Behavior, and Nitric Oxide,” Ann. N.Y. Acad. Sci. 962 (2002), pp. 372-377.
Wang, M. et al., “Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium),” Journal of Pharmacy and Pharmacology 53 (2001), pp. 1515-1523.
Kim, H.-M. et al., “Activation of inducible nitric oxide synthase by Taraxacum officinale in mouse peritoneal macrophages,” General Pharmacology 32 (1999), pp. 683-688.
Yuan, C.-S. et al., “Panax Quinquefolium L. Inhibits Thrombin-Induced Endothelin Release In Vitro,” American Journal of Chinese Medicine, vol. XXVII, Nos. 3-4 (1999), pp. 331-338.
Boveris, A. et al., “Effect of nitric oxide and plant antioxidants on microsomal content of lipid radicals,” Biol. Res. 33 (2000), pp. 159-165.
Author Unknown, “Monograph: Taraxacum officinale,” Alternative Medicine Review, vol. 4, No. 2 (1999), pp. 112-114.
The Patent Office of the People
Mantione Kirk
Stefano George B.
Zhu Wei
Hoffman Warnick LLC
Rook David E.
Tate Christopher R
The Research Foundation at State University of New York
Winston Randall
LandOfFree
Nitric oxide and its biomedical significance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitric oxide and its biomedical significance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide and its biomedical significance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2655185